Evidence map›Paper›PMID 40231207›Full record

ReviewBiomaterials research2025

The Application of Stem Cells and Exosomes in Promoting Nerve Conduits for Peripheral Nerve Repair.

Mengen Li, Ye Tang, Chengkai Zhou, Yan Geng, Chenxi Zhang, Yuwei Hsu, Le Ma, Wei Guo, Ming Li, Yanhua Wang

Abstract readReview
In one paragraph

Review in Biomaterials research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Engineering Silk Fibroin-Based Biomaterials for Neural Repair.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mengen LiNational Center for Trauma Medicine, Beijing 100044, China.ORCID https://orcid.org/0009-0005-8710-7103
Ye TangNational Center for Trauma Medicine, Beijing 100044, China.
Chengkai ZhouNational Center for Trauma Medicine, Beijing 100044, China.
Yan GengNational Center for Trauma Medicine, Beijing 100044, China.
Chenxi ZhangNational Center for Trauma Medicine, Beijing 100044, China.
Yuwei HsuNational Center for Trauma Medicine, Beijing 100044, China.
Le MaNational Center for Trauma Medicine, Beijing 100044, China.
Wei GuoEmergency Department, Peking University People's Hospital, Beijing 100044, China.
Ming LiNational Center for Trauma Medicine, Beijing 100044, China.
Yanhua WangNational Center for Trauma Medicine, Beijing 100044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The repair of peripheral nerve injury (PNI) presents a multifaceted and protracted challenge, with current therapeutic approaches failing to achieve optimal repair outcomes, thereby not satisfying the considerable clinical demand. The advent of tissue engineering has led to a growing body of experimental evidence indicating that the synergistic application of nerve conduits, which provide structural guidance, alongside the biological signals derived from exosomes and stem cells, yields superior therapeutic results for PNI compared to isolated interventions. This combined approach holds great promise for clinical application. In this review, we present the latest advancements in the treatment of PNI through the integration of stem cells or exosomes with nerve conduits. We have addressed the inadequate efficiency of exosomes or stem cells in conjunction with nerve conduits from 3 perspectives: enhancing stem cells or exosomes, improving nerve conduits, and incorporating physical stimulation.

Identifiers

PMID40231207
PMCPMC11994886

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.